People · Operator
Named in public records as an officer, director or promoter · active 2010–2025 · Pharmaceuticals, Medical Devices, Biotechnology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $140.2M | $703.0M | 2010 |
| Acuamark Diagnostics, Inc. | — | Medical Devices | Series A | $20.3M | $25.6M | 2022 |
| Liberate Medical, Inc. | — | Biotechnology | Series A | $5.9M | $13.6M | 2025 |
| Revon Systems, Inc. | — | Software / Tech | Seed | $4.5M | $15.5M | 2013 |
Cedric Francois at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Cedric Francois on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alec Machiels | 2 | 3 |
| Pascal Deschatelets | 2 | 2 |
| Gerald Chan | 1 | 13 |
| John Moore | 1 | 12 |
| Stephanie O'Brien | 1 | 7 |
| Joseph Smith | 1 | 7 |
| John Landry | 1 | 6 |
| Andrew ` Offer | 1 | 5 |
| David Watson | 1 | 4 |
| Brian Carr | 1 | 3 |
| Sinclair Dunlop | 1 | 3 |
| Douglas Onsi | 1 | 3 |
| Ted Smith | 1 | 3 |
| John J. Moore | 1 | 3 |
| Gregory Murdock | 1 | 3 |
| William Gedale | 1 | 2 |
| David Darst | 1 | 2 |
| Michael Hanbury | 1 | 2 |
| A. Sinclair Dunlop | 1 | 2 |
| Marie-Claude Bernal | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.